Zacks Investment Research on MSN
ANGO expands NanoKnife in Europe for multi-organ tumor ablation
AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical ...
(WNDU) - Prostate cancer is one of the most common types of cancer in men, as almost 35,000 will die from it this year. It develops when abnormal cells form and grow in the prostate gland. Now, there ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
More than $25,000 was donated so Thomas Reid can get the NanoKnife procedure in Ontario.
CLEVELAND, Oh. - It’s the leading cause of cancer deaths in men 65 and older. Traditional treatment includes chemotherapy, immunotherapy and radiation. Urologist Dr. Ruben Olivares specializes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results